Patient Name : MR. G.
VENKATARAMANA Patient ID : 67382
Age/Gender : 60 years, Male Collected On : Feb 19, 2025, 05:49 p.m.
Mobile No : Reported On : Feb 19, 2025, 07:02 p.m.
Referral : SELF Organization : 1APVSK1431
Your Health Trend Report
Glycosylated Hemoglobin (GHb/HBA1c) :
Test Name - (Unit) 19 Feb 25
HbA1c - (%)
Normal Ranges : < 6.0 : Non Diabetic
6.1 – 6.5 : Prediabetic
6.6 – 7.0 : Good Control
7.1-8.0 : POOR Control
>8.1 : ALERT
Estimated Average Glucose (eAG) - (%)
Normal Ranges : 70 - 136
DESCRIPTION PARAMETERS
Investigation 19 Feb 25
Page 1
Patient Name : MR. [Link] Patient ID : 67382
Age/Gender : 60 years, Male Collected On : Feb 19, 2025, 05:49 p.m.
Mobile No : Reported On : Feb 19, 2025, 07:02 p.m.
Referral : SELF Organization : 1APVSK1431
Your Health Trend Report
Excellent Control: 6 to 7 %
Fair to Good Control: 7 to 8 %
Unsatisfactory Control: 8 to 10 %
and Poor Control: More than 10%.
Factors Influencing HbA1c Results: Increased levels: Elevated fetal hemoglobin, chronic renal failure, iron
deficiency anemia, splenectomy, heightened serum triglycerides, alcohol consumption, poisoning (Lead, Opiate), and
salicylate therapy. Decreased levels: are often associated with systemic inflammatory diseases and reduced RBC life
span, severe iron deficiency & haemolytic anaemia, chronic renal failure, and liver diseases. Clinical correlation
reduced red blood cell lifespan (such as in hemolytic anemia or blood loss), following blood transfusions, during
pregnancy, excessive intake of Vitamin E or Vitamin C, and hemoglobinopathies, For HbF > 25% and homozygous
Interpretation: hemoglobinopathy, an alternate platform (Fructosamine) is recommended for testing of HbA1c.
• HbA1c, also known as glycosylated hemoglobin or glycated hemoglobin, refers to hemoglobin that has glucose
molecules attached. It gives an average of glucose levels in the bloodstream for the preceding 2 to 3 months.
• HbA1c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines for the diagnosis
of diabetes using a cut-off point of 6.5%.
• For diabetic patients achieving treatment objectives, the HbA1c test should be conducted at least biannually. If
treatment objectives are not met or if a new regimen is initiated, testing once every 3 months is recommended.
• The HbA1c target for non-pregnant adults is generally set at below 7% to prevent microvascular complications.
• In known diabetic patients, the following values can be considered as a tool for monitoring glycemic control.
Associated tests: HOMA IR index, insulin, C-peptide levels.
Page 2